Literature DB >> 1431141

The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex.

R Krumdieck1, M Höök, L C Rosenberg, J E Volanakis.   

Abstract

Decorin, a small collagen-binding dermatan sulfate proteoglycan, is widely distributed as a component of extracellular matrices. Using a solid phase binding assay, we showed that decorin bound C1q at physiologic pH and ionic strength. The interaction did not require divalent cations and was time and temperature dependent reaching equilibrium in 4 h at 37 degrees C. Binding was specific and saturable with an apparent dissociation constant of 7.6 x 10(-9) M. Decorin was shown to bind pepsin-derived fragments containing the collagenous domain of C1q and collagenase-derived fragments containing the globular domain of C1q. Because these fragments share a short sequence of amino acids, this finding suggests that decorin binds to a region of C1q located near the junction of the two domains. Competition studies using purified preparations of the decorin core protein and the glycosaminoglycan chains showed that only the former inhibited binding of decorin to C1q indicating that the interaction is mediated by the decorin core protein. Decorin was shown to inhibit the hemolytic activity of purified C1 as well as C1 in normal human serum. Approximately 50% inhibition was observed at a decorin concentration of 2 micrograms/ml. Inhibition was not observed if C1 was bound to Ag-complexed antibody. Furthermore, neither the core protein nor the glycosaminoglycan chain of decorin inhibited C1, indicating that the intact proteoglycan is necessary for functional activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431141

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

2.  Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.

Authors:  Simone Buraschi; Nutan Pal; Nadia Tyler-Rubinstein; Rick T Owens; Thomas Neill; Renato V Iozzo
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

3.  Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.

Authors:  Hee Young Hwang; Marcus R Duvall; Stephen Tomlinson; Robert J Boackle
Journal:  Mol Immunol       Date:  2008-03-03       Impact factor: 4.407

4.  Dermatopontin interacts with transforming growth factor beta and enhances its biological activity.

Authors:  O Okamoto; S Fujiwara; M Abe; Y Sato
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

5.  Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo.

Authors:  Sheri L Peterson; Hal X Nguyen; Oscar A Mendez; Aileen J Anderson
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

Review 6.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

Review 7.  Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions.

Authors:  Maria A Gubbiotti; Sylvain D Vallet; Sylvie Ricard-Blum; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-30       Impact factor: 11.583

8.  Adherence of Borrelia burgdorferi to the proteoglycan decorin.

Authors:  B P Guo; S J Norris; L C Rosenberg; M Höök
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  A central role for decorin during vertebrate convergent extension.

Authors:  Jason J Zoeller; Wittaya Pimtong; Helen Corby; Silvia Goldoni; Alex E Iozzo; Rick T Owens; Shiu-Ying Ho; Renato V Iozzo
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

10.  Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice.

Authors:  S Nuka; W Zhou; S P Henry; C M Gendron; J B Schultz; T Shinomura; J Johnson; Y Wang; D R Keene; R Ramírez-Solis; R R Behringer; M F Young; M Höök
Journal:  Osteoarthritis Cartilage       Date:  2009-11-18       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.